Diagnosis of Alzheimer’s disease utilizing amyloid and tau as fluid biomarkers

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

High performance plasma amyloid-β biomarkers for Alzheimer’s disease

(2018) Akinori Nakamura et al.   NATURE

Relevance of Aβ42/40 Ratio for Detection of Alzheimer Disease Pathology in Clinical Routine: The PLMR Scale

(2018) Sylvain Lehmann et al.   Frontiers in Aging Neuroscience

Amyloid-β 42/40 Cerebrospinal Fluid Concentration Ratio in the Diagnostics of Alzheimer's Disease: Validation of Two Novel Assays

(2018) Piotr Lewczuk et al.   JOURNAL OF ALZHEIMERS DISEASE

Aβ42/Aβ40 and Aβ42/Aβ38 Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer’s Disease: A Pilot Study

(2018) Ivan Koychev et al.   JOURNAL OF ALZHEIMERS DISEASE

A two-step immunoassay for the simultaneous assessment of Aβ38, Aβ40 and Aβ42 in human blood plasma supports the Aβ42/Aβ40 ratio as a promising biomarker candidate of Alzheimer’s disease

(2018) Hedieh Shahpasand-Kroner et al.   Alzheimers Research & Therapy

Diagnostic Biomarkers of Alzheimer’s Disease as Identified in Saliva using 1H NMR-Based Metabolomics

(2017) Ali Yilmaz et al.   JOURNAL OF ALZHEIMERS DISEASE

Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer’s disease

(2017) T M Shah et al.   MOLECULAR PSYCHIATRY

Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease

(2016) Piotr Lewczuk et al.   JOURNAL OF ALZHEIMERS DISEASE

NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls

(2016) João Figueira et al.   Molecular BioSystems

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

(2016) Shorena Janelidze et al.   Annals of Clinical and Translational Neurology

Guidelines for the standardization of preanalytic variables for blood-based biomarker studies in Alzheimer's disease research

(2015) Sid E. O'Bryant et al.   Alzheimers & Dementia

Melanopsin retinal ganglion cell loss in Alzheimer disease

(2015) Chiara La Morgia et al.   ANNALS OF NEUROLOGY

Tau Protein Detection in Anosmic Alzheimer’s Disease Patient’s Nasal Secretions

(2015) G. C. Passali et al.   Chemosensory Perception

Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease

(2015) Katarzyna Adamczuk et al.   Alzheimers Research & Therapy

Detection of Amyloid β Signature in the Lens and Its Correlation in the Brain to Aid in the Diagnosis of Alzheimer’s Disease

(2014) Charles Kerbage et al.   American Journal of Alzheimers Disease and Other Dementias

Novel plasma biomarker surrogating cerebral amyloid deposition

(2014) Naoki KANEKO et al.   PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES

Biochemistry of Amyloid  -Protein and Amyloid Deposits in Alzheimer Disease

(2013) C. L. Masters et al.   Cold Spring Harbor Perspectives in Medicine

Fluid Biomarkers in Alzheimer Disease

(2013) K. Blennow et al.   Cold Spring Harbor Perspectives in Medicine

The Neuropsychological Profile of Alzheimer Disease

(2013) S. Weintraub et al.   Cold Spring Harbor Perspectives in Medicine

Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer’s, but not in frontotemporal dementia

(2012) Mirko Bibl et al.   JOURNAL OF NEURAL TRANSMISSION

Alzheimer’s Disease in the Retina: Imaging Retinal Aß Plaques for Early Diagnosis and Therapy Assessment

(2012) Yosef Koronyo et al.   Neurodegenerative Diseases

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

A Blood-Based Algorithm for the Detection of Alzheimer’s Disease

(2011) Sid E. O’Bryant et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Epidemiology of Alzheimer disease

(2011) Christiane Reitz et al.   Nature Reviews Neurology

CSF tau markers are correlated with hippocampal volume in Alzheimer's disease

(2011) Leonardo C. de Souza et al.   NEUROBIOLOGY OF AGING

Testing the Right Target and Right Drug at the Right Stage

(2011) R. A. Sperling et al.   Science Translational Medicine

The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes

(2010) Laurel A. Beckett et al.   Alzheimers & Dementia

Correlation of Longitudinal Cerebrospinal Fluid Biomarkers With Cognitive Decline in Healthy Older Adults

(2010) Erik Stomrud et al.   ARCHIVES OF NEUROLOGY

Saliva levels of Abeta1-42 as potential biomarker of Alzheimer's disease: a pilot study

(2010) Felix Bermejo-Pareja et al.   BMC Neurology

Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model

(2010) Maya Koronyo-Hamaoui et al.   NEUROIMAGE

Alzheimer's Disease Amyloid-β Links Lens and Brain Pathology in Down Syndrome

(2010) Juliet A. Moncaster et al.   PLoS One

Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain

(2009) Tero Tapiola et al.   ARCHIVES OF NEUROLOGY

Beta Amyloid in Alzheimer's Disease: Increased Deposition in Brain Is Reflected in Reduced Concentration in Cerebrospinal Fluid

(2009) Timo Grimmer et al.   BIOLOGICAL PSYCHIATRY

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

(2009) Clifford R. Jack et al.   BRAIN

Amyloid precursor protein processing and retinal pathology in mouse models of Alzheimer’s disease

(2009) R. Michael Dutescu et al.   GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY

CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment

(2009) Niklas Mattsson   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Combined CSF tau, p-tau181 and amyloid-β 38/40/42 for diagnosing Alzheimer’s disease

(2009) Volker Welge et al.   JOURNAL OF NEURAL TRANSMISSION

Relationship of Cerebrospinal Fluid Markers to 11C-PiB and 18F-FDDNP Binding

(2009) N. Tolboom et al.   JOURNAL OF NUCLEAR MEDICINE

Plasma β Amyloid and the Risk of Alzheimer Disease and Dementia in Elderly Men

(2008) Johan Sundelöf et al.   ARCHIVES OF NEUROLOGY

Evaluation of plasma Aβ40 and Aβ42 as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

(2008) Oskar Hansson et al.   NEUROBIOLOGY OF AGING

Increasing CSF phospho-tau levels during cognitive decline and progression to dementia

(2007) Christin Andersson et al.   NEUROBIOLOGY OF AGING

Prediction and longitudinal study of CSF biomarkers in mild cognitive impairment

(2007) Miroslaw Brys et al.   NEUROBIOLOGY OF AGING